Venus Remedies oncology wing product registrations go up to 506 with marketing approvals from 4 more countries
The company has secured 506 marketing approvals for its oncology products across 76 countries.
The company has secured 506 marketing approvals for its oncology products across 76 countries.
Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy
In March 2023, Japan’s Ministry of Health and Labor Welfare approved Novo Nordisk’s once-weekly subcutaneous glucagon-like peptide-1
The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023
Tiotropium (as bromide monohydrate) 18 micrograms powder for inhalation in capsule
Preclina is renowned for its highly specialized services in autoimmune and inflammatory disorders
Zurletrectinib was developed to treat advanced or metastatic solid tumors harboring NTRK fusion genes
The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted by AstraZeneca
Subscribe To Our Newsletter & Stay Updated